• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

AMN Healthcare Completes Acquisition of MSDR

Share:

December 4, 2023

AMN Healthcare (NYSE: AMN) finalizes the acquisition of MSDR, comprising Medical Search International and DRW Healthcare Staffing, focusing on locum tenens and advanced practices. The deal’s impact on AMN’s Q4 2023 financials is anticipated to be negligible. As a frontrunner in healthcare talent solutions, AMN strengthens its portfolio by integrating these specialized healthcare staffing entities, emphasizing locum tenens and advanced practices, aligning with its commitment to healthcare organizations across the US.

AMN Healthcare (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced it has closed on the acquisition of MSDR. MSDR consists of two healthcare staffing companies that specialize in locum tenens and advanced practices, Medical Search International and DRW Healthcare Staffing.

The Company expects the MSDR acquisition to have an immaterial contribution to AMN’s consolidated financial results for the fourth quarter of 2023.

Source: Bio Space

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • BurstIQ Acquires Olive AI’s Business Intelligence PlatformBurstIQ Acquires Olive AI’s Business Intelligence Platform
  • Therapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 MillionTherapix Biosciences Signs LOI to Merge With Destiny Biosciences Global Corp. in a Stock for Stock Transaction Valuing Therapix at US$48 Million
  • Cardiology Startup Vector Remote Care Racks up $12.5M in Series A RoundCardiology Startup Vector Remote Care Racks up $12.5M in Series A Round
  • The Future Of Healthcare WearablesThe Future Of Healthcare Wearables
  • WebMD Acquires AdditudeWebMD Acquires Additude
  • Setting the Foundation for New Ideas to GrowSetting the Foundation for New Ideas to Grow
  • Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd.Johnson & Johnson Announces Offer to Acquire Ci:z Holdings Co., Ltd.
  • Contributed: Discipline During a Gold Rush? Yes, Now More Than Ever When Healthcare Data is InvolvedContributed: Discipline During a Gold Rush? Yes, Now More Than Ever When Healthcare Data is Involved

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications